Citadel Advisors LLC
- SEC CIK
- 0001423053
- Latest filing
- Sep 1, 2026
PTIX holding history
Protagenic Therapeutics, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PTIX overviewAll 13F holders of PTIXFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −23,311−100.0% | Sold out | Holders |
| Q4 2025 | 23,311 | $30.3K | <0.1% | +23,311 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −40,909−100.0% | Sold out | Holders |
| Q3 2024 | 40,909 | $26.0K | <0.1% | +40,909 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −5,871−100.0% | Sold outConverted for a 1-for-4 split | Holders |
| Q4 2022 | 23,482 | $9.81K | <0.1% | +7,352+45.6% | Added | Holders |
| Q3 2022 | 16,130 | $9.00K | <0.1% | +1,677+11.6% | Added | Holders |
| Q2 2022 | 14,453 | $10.0K | <0.1% | +14,453 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −38,712−100.0% | Sold out | Holders |
| Q3 2021 | 38,712 | $72.0K | <0.1% | +38,712 | New | Holders |